Bayer Brings Nearly 30 Debuts to China Expo
Healthcare and agri-input companies selling into China can watch how multinationals use the CIIE to launch products.
Updated on Nov. 5, 2026 in Healthcare
Live Poll
Do you trust large drugmakers to bring useful new medicines to everyday people?
Bayer is attending the ninth China International Import Expo (CIIE) in Shanghai, opened November 5, 2026, presenting nearly 30 debuts across healthcare and agriculture. Operators in medical products, consumer health and agri-inputs should note the event as a channel for launching global products into China.
Why it matters
Bayer is positioning its Pharmaceuticals, Consumer Health and Crop Science divisions to integrate China's needs and local insights into its global R&D network. For companies selling into China, a large multinational using the CIIE as a launch platform signals how foreign firms are approaching the market.
Bayer has attended the CIIE for nine consecutive years and is presenting nearly 30 debuts across disease treatment, precision diagnostics, self-care and agriculture. The company has operated in China for 145 years by 2027, within a history of more than 160 years.
The players
Bayer
A multinational life sciences company with pharmaceuticals, consumer health and crop science divisions, with more than 160 years of operating history.
The details
Bayer is showcasing products through booths in the Medical Equipment & Healthcare Products Exhibition Area and the Food and Agricultural Products Exhibition Area, with a dual presence at Booth A3-03 in Hall 1.1 and Booth B3-02 in Hall 8.1. The company describes the CIIE as a way to accelerate introducing global innovations to China. Bayer also says it is folding China's needs and local insights back into its global research and development network.
Timeline
November 5, 2026: Ninth CIIE opens in Shanghai with Bayer attending.
2027: Bayer marks 145 years of presence in China.
Market Landscape
Multinational healthcare and agriculture firms are using the China International Import Expo as a recurring launch channel rather than a one-time event. Bayer's nine-year attendance record places it among the sustained foreign exhibitors in the medical and agricultural product areas.
Companies selling medical, consumer health or agricultural products into China should track trade-fair launch cycles as a route to market entry. Operators in these sectors may want to assess how global innovation pipelines are being localized for Chinese demand.
The takeaway
Multinationals are treating the CIIE as a sustained market-entry venue, so operators in healthcare and agriculture should monitor which product debuts progress to commercial availability in China. Tracking Bayer's 2027 anniversary communications may indicate how its China strategy develops.
Further reading
For more on how healthcare companies are moving into new markets, see our Healthcare coverage.
Source note: This article includes information reported by China Daily.
Live Poll
Do you trust large drugmakers to bring useful new medicines to everyday people?
